12:58 PM
 | 
Nov 04, 2016
 |  BC Week In Review  |  Company News  |  Deals

Takeda, MSKCC, Rockefeller and Weill deal

Memorial Sloan Kettering Cancer Center, Rockefeller University and Weill Cornell Medical College launched Bridge Medicines, a drug discovery company designed to advance candidates developed at the partners' Tri-Institutional Therapeutics Discovery Institute Inc. (Tri-I TDI). The research group said...

Read the full 170 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >